DUSA Pharmaceuticals (DUSA) Reports In-Line Q2 EPS of 6c

DUSA Pharmaceuticals (NASDAQ: DUSA) reported Q2 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $11.7 million versus the consensus estimate of $11.85 million.

For earnings history and earnings-related data on DUSA Pharmaceuticals (DUSA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Arena Group to rename as Paradium.AI, ticker changing to PAAI
• Investing.com’s stocks of the week